CN101157725B - 人胰岛素类似物的制备方法及用途 - Google Patents
人胰岛素类似物的制备方法及用途 Download PDFInfo
- Publication number
- CN101157725B CN101157725B CN2007101338674A CN200710133867A CN101157725B CN 101157725 B CN101157725 B CN 101157725B CN 2007101338674 A CN2007101338674 A CN 2007101338674A CN 200710133867 A CN200710133867 A CN 200710133867A CN 101157725 B CN101157725 B CN 101157725B
- Authority
- CN
- China
- Prior art keywords
- human insulin
- insulin analogue
- insulin
- fppins
- analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101338674A CN101157725B (zh) | 2007-10-24 | 2007-10-24 | 人胰岛素类似物的制备方法及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101338674A CN101157725B (zh) | 2007-10-24 | 2007-10-24 | 人胰岛素类似物的制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101157725A CN101157725A (zh) | 2008-04-09 |
CN101157725B true CN101157725B (zh) | 2012-07-25 |
Family
ID=39305972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101338674A Expired - Fee Related CN101157725B (zh) | 2007-10-24 | 2007-10-24 | 人胰岛素类似物的制备方法及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101157725B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014052451A2 (en) | 2012-09-26 | 2014-04-03 | Indiana University Research And Technology Corporation | Insulin analog dimers |
UY36870A (es) * | 2015-08-28 | 2017-03-31 | Hanmi Pharm Ind Co Ltd | Análogos de insulina novedosos |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005012347A2 (en) * | 2003-08-05 | 2005-02-10 | Novo Nordisk A/S | Novel insulin derivatives |
WO2006082205A1 (en) * | 2005-02-02 | 2006-08-10 | Novo Nordisk A/S | Insulin derivatives |
CN1829738A (zh) * | 2003-08-05 | 2006-09-06 | 诺沃挪第克公司 | 新型胰岛素衍生物 |
-
2007
- 2007-10-24 CN CN2007101338674A patent/CN101157725B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005012347A2 (en) * | 2003-08-05 | 2005-02-10 | Novo Nordisk A/S | Novel insulin derivatives |
CN1829738A (zh) * | 2003-08-05 | 2006-09-06 | 诺沃挪第克公司 | 新型胰岛素衍生物 |
WO2006082205A1 (en) * | 2005-02-02 | 2006-08-10 | Novo Nordisk A/S | Insulin derivatives |
Also Published As
Publication number | Publication date |
---|---|
CN101157725A (zh) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104804096B (zh) | 长效多肽及其生产和施用方法 | |
CN101519446A (zh) | 一种重组人胰岛素及其类似物的制备方法 | |
CN101240033B (zh) | 一种促胰岛素分泌肽与人血清白蛋白的融合蛋白及其制备方法 | |
CN108060195A (zh) | 一种发酵生产重组胰高血糖素样肽-1蛋白的方法 | |
CN101157725B (zh) | 人胰岛素类似物的制备方法及用途 | |
CN112851791B (zh) | 一种新型抗代谢紊乱的fgf类似物及其应用 | |
CN102443064A (zh) | 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用 | |
CN113105561B (zh) | 一种双靶点融合蛋白的制备方法和应用 | |
JP6612360B2 (ja) | 薬用作用を有する融合タンパク質複合体および融合タンパク質 | |
CN107033234A (zh) | 酰化的glp‑1衍生物 | |
AU2014336815A1 (en) | Fusion protein of ganoderma lucidum immunoregulatory protein and human serum albumin, and production method therefor and uses thereof | |
CN111378027A (zh) | 一种索玛鲁肽前体的制备方法 | |
CN106008717B (zh) | 一种长效重组glp-1融合蛋白及其制备方法和用途 | |
CN101935346A (zh) | 突变的人源成纤维生长因子及在治疗内分泌疾病中的用途 | |
CN103554270A (zh) | 一种新型重组蛋白及其制备和应用 | |
CN102796192A (zh) | 人胰高血糖素相关肽-1类似物 | |
CN100418983C (zh) | 人胰高血糖素相关肽-2类似物 | |
CN101544692B (zh) | 棕果蝠瘦素蛋白及其cDNA序列 | |
CN101863982A (zh) | 一种用于升高血小板的融合蛋白及其制备方法 | |
CN109776653B (zh) | 一种人血清白蛋白黏附肽及其应用 | |
CN113880954A (zh) | 一种重组人生长激素及其构建方法和应用 | |
CN101824388A (zh) | 一种糖尿病食疗酵母及其构建方法 | |
CN101062948B (zh) | 单体速效胰岛素及其制法和用途 | |
CN101544981A (zh) | 一种具有降血糖生物活性的苦瓜多肽基因工程制备方法及应用 | |
CN102260346A (zh) | 一种Exendin-4类似物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU WEIMING TIANREN BIO-PHARMACEUTICAL CO., LT Free format text: FORMER OWNER: CHINA PHARMACEUTICAL UNIVERSITY Effective date: 20140404 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 211198 NANJING, JIANGSU PROVINCE TO: 213000 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140404 Address after: 213000 Jiangsu city of Changzhou province Hehai West New District No. 106 Fangyuan incubator Patentee after: Jiangsu wenmingtianren Biological Medicine Co Ltd Address before: No. 639 Jiangning longmian Road District of Nanjing City, Jiangsu province 211198 Patentee before: China Pharmaceutical University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20141024 |
|
EXPY | Termination of patent right or utility model |